Corvus Pharmaceuticals, Inc.

NasdaqGM:CRVS Stock Report

Market Cap: US$575.1m

Corvus Pharmaceuticals, Inc. Company Information

Corvus Pharmaceuticals, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Corvus Pharmaceuticals, Inc.
  • Ticker: CRVS
  • Exchange: NasdaqGM
  • Founded: 2014
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$575.102m
  • Shares Outstanding: 64.26m
  • Website: https://www.corvuspharma.com

Number of Employees

Location

  • Corvus Pharmaceuticals, Inc.
  • 863 Mitten Road
  • Suite 102
  • Burlingame
  • California
  • 94010
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CRVSNasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDMar 2016
C17DB (Deutsche Boerse AG)YesCommon StockDEEURMar 2016

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/25 10:42
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.